342 related articles for article (PubMed ID: 18709046)
21. Loss of heterozygosity in 73 human thyroid tumors.
Wozniak A; Wiench M; Olejniczak A; Wloch J; Lachinski A; Lange D; Olczyk T; Jarzab B; Limon J
Neuro Endocrinol Lett; 2005 Oct; 26(5):521-5. PubMed ID: 16264407
[TBL] [Abstract][Full Text] [Related]
22. Primary thyroid malignancies in Tehran, Iran.
Larijani B; Mohagheghi MA; Bastanhagh MH; Mosavi-Jarrahi AR; Haghpanah V; Tavangar SM; Bandarian F; Khaleghian N
Med Princ Pract; 2005; 14(6):396-400. PubMed ID: 16220012
[TBL] [Abstract][Full Text] [Related]
23. Primary tumour diameter as a risk factor for advanced disease features of differentiated thyroid carcinoma.
Verburg FA; Mäder U; Luster M; Reiners C
Clin Endocrinol (Oxf); 2009 Aug; 71(2):291-7. PubMed ID: 19067727
[TBL] [Abstract][Full Text] [Related]
24. Comorbidity in newly diagnosed thyroid cancer patients: a population-based study on prevalence and the impact on treatment and survival.
Kuijpens JL; Janssen-Heijnen ML; Lemmens VE; Haak HR; Heijckmann AC; Coebergh JW
Clin Endocrinol (Oxf); 2006 Apr; 64(4):450-5. PubMed ID: 16584519
[TBL] [Abstract][Full Text] [Related]
25. Primary malignant tumours associated with thyroid carcinoma in autopsy material.
Tiszlavicz L; Varga Z
Acta Morphol Hung; 1992; 40(1-4):95-102. PubMed ID: 1365776
[TBL] [Abstract][Full Text] [Related]
26. Risk of malignant tumors in first-degree relatives of patients with differentiated thyroid cancer -- a hospital based study.
Handkiewcz-Junak D; Banasik T; Kolosza Z; Roskosz J; Kukulska A; Puch Z; Jarzab B
Neoplasma; 2006; 53(1):67-72. PubMed ID: 16416016
[TBL] [Abstract][Full Text] [Related]
27. A time trend analysis of papillary and follicular cancers as a function of tumour size: a study of data from six cancer registries in France (1983-2000).
Colonna M; Guizard AV; Schvartz C; Velten M; Raverdy N; Molinie F; Delafosse P; Franc B; Grosclaude P
Eur J Cancer; 2007 Mar; 43(5):891-900. PubMed ID: 17289376
[TBL] [Abstract][Full Text] [Related]
28. Thyroid malignancy in endemic nodular goitres: prevalence, pattern and treatment.
Lawal O; Agbakwuru A; Olayinka OS; Adelusola K
Eur J Surg Oncol; 2001 Mar; 27(2):157-61. PubMed ID: 11289751
[TBL] [Abstract][Full Text] [Related]
29. Parotid and thyroid gland cancers in patients with ataxia-telangiectasia.
Sandoval C; Schantz S; Posey D; Swift M
Pediatr Hematol Oncol; 2001 Dec; 18(8):485-90. PubMed ID: 11764097
[TBL] [Abstract][Full Text] [Related]
30. High recurrent rate of multicentric papillary thyroid carcinoma.
Lin JD; Chao TC; Hsueh C; Kuo SF
Ann Surg Oncol; 2009 Sep; 16(9):2609-16. PubMed ID: 19533244
[TBL] [Abstract][Full Text] [Related]
31. Incidence and clinical behavior of papillary thyroid carcinoma in renal allograft recipients: a single center experience.
Lee J; Jeong JJ; Lee YS; Nam KH; Chang HS; Chung WY; Soh EY; Kim YS; Park CS
Transplant Proc; 2008 Dec; 40(10):3751-4. PubMed ID: 19100481
[TBL] [Abstract][Full Text] [Related]
32. [The effect of gender on prevalence and survival in thyroid carcinoma].
Nĕmec J; Chytrý P; Dvorák J; Vlcek P; Neradilová M; Racek P; Blazek T; Zeman V
Vnitr Lek; 1996 Sep; 42(9):602-4. PubMed ID: 8984765
[TBL] [Abstract][Full Text] [Related]
33. Thyroid cancer in Lebanese children and adolescents: a 15-year experience at a single institution.
Dardas M; Abboud M; Salti I; Sabri A; Shoucair M; Saleh M; Azar S; Rodriguez-Galindo C; Muwakkit S
Pediatr Hematol Oncol; 2009 Sep; 26(6):439-47. PubMed ID: 19657994
[TBL] [Abstract][Full Text] [Related]
34. Influence of previous radiation exposure on pathologic features and clinical outcome in patients with thyroid cancer.
Seaberg RM; Eski S; Freeman JL
Arch Otolaryngol Head Neck Surg; 2009 Apr; 135(4):355-9. PubMed ID: 19380356
[TBL] [Abstract][Full Text] [Related]
35. Thyroid disease in the west of Ireland: an atypical incidence of neoplasia.
O'Hanlon DM; Little MP; Given HF; Quill DS
Ir Med J; 1997 Mar; 90(2):70-1. PubMed ID: 9105132
[TBL] [Abstract][Full Text] [Related]
36. Descriptive epidemiology of thyroid cancer in Osaka.
Hanai A; Fujimoto I
Natl Cancer Inst Monogr; 1982; 62():201-6. PubMed ID: 7167190
[TBL] [Abstract][Full Text] [Related]
37. Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project.
Steliarova-Foucher E; Stiller CA; Pukkala E; Lacour B; Plesko I; Parkin DM
Eur J Cancer; 2006 Sep; 42(13):2150-69. PubMed ID: 16919778
[TBL] [Abstract][Full Text] [Related]
38. Iodine intake and incidence of thyroid cancer in Denmark.
Sehestedt T; Knudsen N; Perrild H; Johansen C
Clin Endocrinol (Oxf); 2006 Aug; 65(2):229-33. PubMed ID: 16886965
[TBL] [Abstract][Full Text] [Related]
39. Simultaneous medullary carcinoma and differentiated thyroid cancer. Case report.
Costanzo M; Marziani A; Papa V; Arcerito MC; Cannizzaro MA
Ann Ital Chir; 2010; 81(5):357-60. PubMed ID: 21294389
[TBL] [Abstract][Full Text] [Related]
40. Changing face of paediatric and adolescent thyroid cancer.
Hameed R; Zacharin MR
J Paediatr Child Health; 2005 Nov; 41(11):572-4. PubMed ID: 16398840
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
